ZFIN ID: ZDB-PUB-190516-20
A transgenic zebrafish model of hepatocyte function in human Z α1-antitrypsin deficiency
Yip, E., Giousoh, A., Fung, C., Wilding, B., Prakash, M.D., Williams, C., Verkade, H., Bryson-Richardson, R.J., Bird, P.I.
Date: 2018
Source: Biological chemistry   400(12): 1603-1616 (Journal)
Registered Authors: Bird, Phillip I., Bryson-Richardson, Robert, Verkade, Heather
Keywords: Danio rerio, SERPINA1, liver, serpin, α1-antitrypsin deficiency
MeSH Terms:
  • Animals
  • CHO Cells
  • Cell Line
  • Cricetulus
  • Hepatocytes/metabolism*
  • Humans
  • Models, Animal*
  • Mutation
  • Zebrafish
  • alpha 1-Antitrypsin/genetics
  • alpha 1-Antitrypsin/metabolism*
  • alpha 1-Antitrypsin Deficiency/genetics
  • alpha 1-Antitrypsin Deficiency/metabolism*
PubMed: 31091192 Full text @ Biol. Chem.
In human α1-antitrypsin deficiency, homozygous carriers of the Z (E324K) mutation in the gene SERPINA1 have insufficient circulating α1-antitrypsin and are predisposed to emphysema. Misfolding and accumulation of the mutant protein in hepatocytes also causes endoplasmic reticulum stress and underpins long term liver damage. Here we describe transgenic zebrafish (Danio rerio) expressing the wildtype or the Z mutant form of human α1- antitrypsin in hepatocytes. As observed in afflicted humans, and in rodent models, about 80% less α1-antitrypsin is evident in the circulation of zebrafish expressing the Z mutant. Although these zebrafish also show signs of liver stress they do not accumulate α1-antitrypsin in hepatocytes. This new zebrafish model will provide useful insights into understanding and treatment of α1-antitrypsin deficiency.